Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases

Fig. 3

FA incorporation into PL and neutral lipid fraction and LD formation. Changes in the FA distribution of B16.F10 tumour cells treated with LysoPC 17:0 over 5 days. a: Lipid fractions, neutral lipids and PL were individually analysed and total FA are displayed as area counts of gas chromatography measurement (n = 4 measurements). b/c: Fluorescence Laser Scanning Microscope images of B16.F10 melanoma cells after staining with DAPI (blue) and BODIPY (green). b: Cells cultivated in control medium DMEM-BSA, c: Cells treated with LysoPC 17:0 (450 μM) for 16 days

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X